• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator?

作者信息

Vine D L

机构信息

Department of Medicine, University of Kansas School of Medicine-Wichita 67214.

出版信息

Kans Med. 1990 May;91(5):147-8.

PMID:2115093
Abstract
摘要

相似文献

1
Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator?急性心肌梗死：链激酶真的与组织型纤溶酶原激活剂一样有效吗？
Kans Med. 1990 May;91(5):147-8.
2
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.接受溶栓治疗的急性心肌梗死女性和男性患者的特征及预后比较。GUSTO-I研究组。
JAMA. 1996 Mar 13;275(10):777-82.
3
Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.20891例急性心肌梗死患者被随机分为接受阿替普酶和链激酶治疗（加或不加肝素），对其进行六个月生存率的研究。GISSI - 2和国际研究小组。意大利心肌梗死生存研究组。
Eur Heart J. 1992 Dec;13(12):1692-7.
4
[GISSI-2; the beginning of the end or the end of the beginning for tissue plasminogen activator in acute myocardial infarct?].[GISSI - 2；组织型纤溶酶原激活剂在急性心肌梗死治疗中是终结的开始还是开始的结束？]
Ned Tijdschr Geneeskd. 1990 May 12;134(19):940-4.
5
tPA fast by GUSTO.GUSTO研究中tPA快速给药方案
Lancet. 1993 May 8;341(8854):1188. doi: 10.1016/0140-6736(93)91011-a.
6
In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
Lancet. 1990 Jul 14;336(8707):71-5.
7
The GUSTO trial: is the open-artery hypothesis proven?
Ann Pharmacother. 1994 Jan;28(1):97-8. doi: 10.1177/106002809402800118.
8
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.与链激酶相比，组织型纤溶酶原激活剂溶栓治疗急性心肌梗死的成本效益。
N Engl J Med. 1995 May 25;332(21):1418-24. doi: 10.1056/NEJM199505253322106.
9
Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results.
Clin Cardiol. 1991 Jul;14(7):549-56.
10
Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.在兔栓塞性中风模型中使用组织型纤溶酶原激活剂类似物和链激酶进行延迟治疗。
Stroke. 1990 Apr;21(4):602-5. doi: 10.1161/01.str.21.4.602.